Great news from the phase 2 trial. Expert says "The combined data from this trial support further development of BNC210 and give us confidence that the drug has the potential to bring relief to sufferers of anxiety and trauma and stress related disorders." A lot of us were waiting for this! This is really good for BNO and the sector in Aus IMO. GLTA (especially those who have hung in there).
Add to My Watchlist
What is My Watchlist?